Crowdonomics
All companies
MicroGen Vet logo

MicroGen Vet

Operating

MicroGen Vet LLC

Biotech · Pittsburg, PA

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$51,390
Across 1 round since 2018
Latest share price
$9.00
Reg CF · Class B Units · Jun 2018 offering price

Financials

FY2016–FY2018 · from SEC filings · hover any figure for its source
$0
2016
$0
$23K
2017
$0
$243K
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2016 reviewed*
FY2017 reviewed
FY2018 reviewed
Income statement
Revenue
$0
$0
$0
Cost of goods sold
$0
$0
$0
Net income
$0
$23,085
$243,041
Taxes paid
$0
$0
$0
Balance sheet
Cash
$0
$19,875
$59,375
Accounts receivable
$0
$2,595
$5,093
Total assets
$0
$22,470
$64,468
Short-term debt
$0
$555
$17,704
Long-term debt
$0
$0
$60,000
Total liabilities
$0
$555
$77,704
Other
Headcount
—
10
10

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Raised $51.4K / $1.1MInvestors 54

Team

6 people
Kurt DombkowskiFounder
Founder, CEO, Managing Member

Animal Wound Care World Wide - Founder, CEO - 2014 - 2017 Kurt Dombkowski, MBA, is an award-winning sales executive who has a record of capturing market share by developing loyal relationships with market influencers since 2001. He is a well respected thought leader for directing strategic initiatives, for his superior industry knowledge and competitive product insight. Kurt has over 17 years of sales and brand management experience as a talented director and mentor from his career with Novartis Pharmaceuticals. He has a deep understanding of Cardiovascular and Diabetes Disease State Management earned from his training in conjunction with the Joslin Diabetes Center at the Harvard Medical School. In 2010 Kurt shifted his focus to Wound Care and Infectious Disease management as the Northeast Director with Pioneer Therapeutics. During his time with Pioneer he built key relationships with industry thought leaders, including; the University of Pittsburgh Medical Center's Wound Value and Analysis Team; Dr William Costerton, Director of the Biofilm Research Center for Genomic Sciences at Allegheny Health Network; and Dr Joseph Cacchione, Chairman of Operations and Strategy at the Cleveland Clinic and current President of Ascension Medical Group, the largest non-profit health system in the US. As full time CEO and Managing Member of MicroGen Vet since September 2017, Kurt leverages his extensive knowledge of Wound Care and Biofilm management and relationships build from Animal Wound Care WW to provide business strategy and to oversee sales channel development for the business.

Raymond RameyFounder
Founder, VP, Managing Member

PhotoPhage Systems LLC - Founder, President 2016 - > Medical diagnostic unit research & development HCC Lens LLC - Founder & President, 2015 - 2017 > Medicare reimbursement software platform Avnet Government Solutions (subsidiary of Avnet Inc.) - General Manager 2012 - 2015) > Public Sector Division for market leading Information Tech product & services distributor Mr. Ramey facilitated the acquisition of Pepperweed Consulting by a publicly traded IT distribution conglomerate. (Fortune 108; $28B annual revenue) in July 2012. Following the acquisition, Mr. Ramey built and ran the company's public sector business and was responsible for business and operational performance of the $850Million/year revenue organization. Ray is an accomplished business executive with a proven track record in finance, strategy, sales, marketing, and operations. Successful business outcomes in diverse industries, geographies and technology markets have been delivered through leadership and ownership roles in both small and large organizations. He is a relationship builder with a record of negotiating complex business relationships and mutually beneficial strategic alliances throughout his career and has been a founder or partner in several startup business ventures resulting in successful exits. As full time VP of Operations and Managing Member for MicroGen Vet since September 2017, Ray provides business acumen and operational skills to develop and drive overall business and operational systems and partnerships. He is responsible for corporate governance and regulatory compliance and oversees funding and investor communications. Mr. Ramey provides ongoing part time advisory services to PhotoPhage Systems ( 5-10 hrs/week). These services will wind down by the end of 2018.

Dr. Bimbo Welker, VMD
Advisor

Dr. Welker is the co-Director of Ohio State University’s department for large animal services. The facility is a full service, 24 hour large animal ambulatory and outpatient, urgent care facility. The mission of the operation is to provide services at competitive pricing while teaching students the business and providing an opportunity to practice medicine in a practice setting. He was presented with the Norden Teaching award for his work at the university. Prior to Ohio State University, Dr. Welker was a respected staff surgeon and Surgery Section Chief at Virginia Tech where he was recognized with 11 teaching awards for his leadership. He has also been awarded the Outstanding Speaker Award by the North American Conference and has special areas of interest including practice & wound management, field anesthesia and practical fluid therapy.

Dr. Bonnie Barr, VMD DACVIM
Advisor

Dr. Barr earned her veterinary degree at the University of Pennsylvania. She then completed a one-year internship at Rood and Riddle Equine Hospital and a two-year internal medicine residency at the University of Pennsylvania’s New Bolton Center. Dr. Barr was a staff member for one year at Texas A&M University before rejoining Rood and Riddle Equine Hospital in 2001 as an associate veterinarian specializing in internal medicine. She became boarded in internal medicine in 2003. Her areas of special interest include equine neonatology, equine infectious diseases and infectious disease control. Dr Barr is the co-author of Equine Pediatrics.

Dr. Stephen Reed, DVM
Advisor

Dr Reed earned his veterinary degree at The University of Ohio. He then completed an internship and residency at Michigan State University. After a period at Washington State University, he returned to The Ohio State University, retiring from there as a professor emeritus in 2007. At the same time he chose a new career path away from academia and is now a shareholder and a member of the Internal Medicine Service at Rood and Riddle Equine Hospital in Lexington, Kentucky. His special interests include Equine Neurology and EPM research.

Richard Martin
Advisor

Rick Martin has over 20 years of global business development, marketing, strategy and leadership experience in the healthcare market. This experience spans start-ups to multi-nationals. Mr. Martin had 20 years of experience with Pfizer Pharmaceuticals where he was responsible for Sales operations for Europe and Canada reporting directly to the VP of Europe/Canada, Ian Read, who is the current CEO of Pfizer. Mr. Martin managed a sales organization covering 21 countries and 11,000 sales representatives. Mr. Martin is the Founder of MicroGen DX which is a company formed for the acquisition of PathoGenius in 2016. Mr. Martin is the Chairman and CEO at MicroGen DX and leads its business development efforts for targeted human markets. Beyond the success that Rick has achieved in business, he is also a former Army officer leading high performance teams and achieving Airborne/ Ranger qualification. The attributes he learned while serving our country are the bedrock of his capability as a leader. Mr. Martin received his Bachelors of Arts from the University of Massachusetts (Amherst). Mr. Martin provides technology and diagnostics strategy advisory services to MicroGen Vet and shares his knowledge with Veterinary Research Universities and other key customers in support of MicroGen Vet.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 8 annual reports (FY2018–FY2025)

54 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-TRApr 27, 20200001665160-20-000419
    EDGAR
  • Form C-ARMay 2, 20190001665160-19-000609
    EDGAR
  • Form C-UApr 16, 20190001665160-19-000358
    EDGAR
  • Form C-UOct 3, 20180001665160-18-001023
    EDGAR
  • Form CJun 28, 20180001665160-18-000624
    EDGAR
Source: SEC EDGARCIK 0001741278DEShare price $9.00Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.